Back to the future 3
A trio of trends that pharma needs to contend with in 2024
Read More
Author: PharmaTimes
Craft work
Modelling the data revolution in clinical drug development
Read More
Precision decision
What to consider when evaluating UK, US or EU for MedTech markets
Read More
Future proofing
MHRA to recognise medicine approvals from trusted partner markets
Read More
Shape shifters
Transitioning from a linear to circular approach in sustainability
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
